Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ortho Regenerative Technologies (ORTIF)

Ortho Regenerative Technologies (ORTIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,858
  • Shares Outstanding, K 34,956
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,930 K
  • 60-Month Beta -1.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ORTIF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.02 on 06/23/22
  • Latest Earnings Date 09/29/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/22
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.02
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1962 unch
on 08/15/22
0.2190 -10.41%
on 08/10/22
-0.0138 (-6.57%)
since 07/12/22
3-Month
0.1290 +52.09%
on 05/23/22
0.2190 -10.41%
on 08/10/22
+0.0014 (+0.72%)
since 05/04/22
52-Week
0.1290 +52.09%
on 05/23/22
0.4500 -56.40%
on 12/13/21
-0.1412 (-41.85%)
since 08/13/21

Most Recent Stories

More News
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX

/PRNewswire/ - Ortho Regenerative Technologies Inc., (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company") a clinical-stage orthobiologics company focused on...

ORTIF : 0.1962 (-7.50%)
ORTH.CN : 0.250 (unch)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX

/CNW Telbec/ - Ortho Regenerative Technologies Inc., (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company") a clinical-stage orthobiologics company focused on...

CHGX.CN : 0.0650 (+8.33%)
ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS

Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023 Philippe Deschamps appointed as new CEO Signing of...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on the...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR

/CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho" or the "Company"), a clinical-stage orthobiologics company focused on the...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS

Phase I/II clinical trial IND application cleared by FDA for testing ORTHO-R in combination with PRP for rotator cuff tear repair ORTHO-R / PRP combination...

ORTH.CN : 0.250 (unch)
ORTIF : 0.1962 (-7.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.1962
2nd Resistance Point 0.1962
1st Resistance Point 0.1962
Last Price 0.1962
1st Support Level 0.1962
2nd Support Level 0.1962
3rd Support Level 0.1962

See More

52-Week High 0.4500
Fibonacci 61.8% 0.3274
Fibonacci 50% 0.2895
Fibonacci 38.2% 0.2516
Last Price 0.1962
52-Week Low 0.1290

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar